Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

New to The Street and Sight & Sound's Visionaries Series Premieres Tonight on Bloomberg, Featuring PetVivo and Its Revolutionary SPRYNG(TM) OsteoCushion(TM) Technology

New to The Street and Sight & Sound are thrilled to announce the premiere of their latest episode in the Visionaries series, airing tonight at 9:30 PM PST on Bloomberg as sponsored programming.

NEW YORK, NY / ACCESSWIRE / September 5, 2024 / New to The Street and Sight & Sound are thrilled to announce the premiere of their latest episode in the Visionaries series, airing tonight at 9:30 PM PST on Bloomberg as sponsored programming. This highly anticipated episode will spotlight PetVivo Holdings, Inc. (OTCQB:PETV,PETVW) and its revolutionary SPRYNG™ product, a ground-breaking solution that is transforming joint health treatment for animals. SPRYNG™, PetVivo's proprietary injectable veterinary medical device, has garnered widespread attention for its effectiveness in the management of osteoarthritis and other musculoskeletal conditions in animals. By mimicking and reinforcing natural joint cartilage, SPRYNG™ offers a breakthrough, drug-free option for veterinarians seeking long-term solutions to improve the quality of life for pets.

Nasdaq Billboard NTTS
Nasdaq Billboard NTTS
NASDAQ

Sneak peek here https://youtu.be/-6jmRoEBRVs?si=hlECEUkRBPorAfMn

Currently, SPRYNG™ has been used in over 800 veterinary clinics across all 50 U.S. states, making it a leading product in veterinary care. This episode of Visionaries takes viewers inside PetVivo's Minnesota lab and offices, where John Lai, CEO of PetVivo, along with leading scientists and veterinary experts, will provide an in-depth exploration of the science behind SPRYNG™ and its transformative impact on animal health.

"We are excited to showcase PetVivo in this new episode of Visionaries, which perfectly aligns with our mission to highlight innovative companies making a difference in their industries," said John Lai, CEO of PetVivo. "SPRYNG™ has the potential to redefine how veterinarians approach joint health, and we are thrilled to bring this story to a national audience."

After airing on Bloomberg, this episode will be distributed across New to The Street's vast digital platforms, including its 1.4 million subscriber YouTube channel and 300,000+ social media followers on Twitter, LinkedIn, and Instagram. The extended reach ensures that the segment will
continue to engage a broad audience well beyond its initial television broadcast.

About PetVivo Holdings, Inc.

PetVivo Holdings, Inc. (OTCQB:PETV, PETVW) is a biomedical device company focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The company is pursuing a strategy of developing and commercializing human therapies for the treatment of companion animals in capital and time efficient ways. A key component of this strategy is an accelerated timeline to revenues for veterinary medical devices that can enter the market much earlier than more stringently regulated human pharmaceuticals and biologics.

PetVivo has developed a robust pipeline of products for the medical treatment of animals and people, with a portfolio of 21 patents that protect the company's biomaterials, products, production processes and methods of use. The company's commercially launched flagship product, Spryng™ with OsteoCushion™

Technology, is a veterinarian-administered, intra-articular injectable designed for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses. For more information about PetVivo and its revolutionary Spryng with OsteoCushion Technology, email info1@petvivo.com or visit petvivo.com or sprynghealth.com.

About New to The Street

New to The Street is a long-running sponsored television program that highlights emerging companies and forward-thinking brands. With nearly two decades of experience, New to The Street has produced over 800 shows, airing on major U.S. networks including FOX Business and Bloomberg. After airing on television, the content is shared on New to The Street's 1.4 million subscriber YouTube channel and across its 300,000+ social media followers on Twitter, LinkedIn, and Instagram, providing continuous exposure for the featured companies.

For media inquiries, please contact:

Contact Information

Monica Brennan
Head of Operations
monica@newtothestreet.com
6316828499

SOURCE: New to The Street



View the original press release on accesswire.com

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.03
+5.55 (2.56%)
AAPL  262.77
+0.53 (0.20%)
AMD  238.03
-2.53 (-1.05%)
BAC  51.52
-0.52 (-1.00%)
GOOG  251.34
-5.68 (-2.21%)
META  733.27
+1.10 (0.15%)
MSFT  517.66
+0.87 (0.17%)
NVDA  181.16
-1.48 (-0.81%)
ORCL  275.15
-2.03 (-0.73%)
TSLA  442.60
-4.83 (-1.08%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.